
BRV Capital Management is a global growth investment platform and the Asia-based, tech-focused growth equity investment arm of BlueRun Ventures. The firm targets category winners that are clearly the most competitive within their respective industries, investing in growth-stage companies.
Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $51.1M (across 20 rounds with reported amounts).
Portfolio
27
Fund Size
—
Top Stage
Series B
Last 12 Mo
3
Team
JC
Jeff Chu
Senior Managing Director
YC
Yeemin Chung
Senior Managing Director
JJ
Jaeyoon Jung
Managing Director
KA
Key Arm Suh
Executive Director
LY
Larry Yea Lam Lee
Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
28 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Pre-Seed | $5.4M | Jan 2026 | |
| Series A | $90M | Jan 2026 | |
| ZZettabyte | Growth | — | Sep 2025 |
| WWRTN | Series B | — | Mar 2025 |
| Series B | $10M | Jul 2024 | |
| Series B | $75M | Jul 2024 | |
| Series B | — | Jun 2024 | |
| WWRTN | Series B | — | Jun 2024 |
| Series B | — | Jan 2024 | |
| MMezzion Pharma | Unknown | $40M | Apr 2023 |
| Unknown | $38.4M | Mar 2023 | |
| Series A | $28M | Mar 2023 | |
| EEst Media | Unknown | $28M | Mar 2023 |
| VVerismo Therapeutics | Seed | $7M | Feb 2023 |
| KKey Proteo | Series A | $5M | Jan 2023 |
| LLine Man Wongnai | Series B | — | Sep 2022 |
| Series C | $100M | Sep 2022 | |
| Series D | $182M | May 2022 | |
| Series B | $21.5M | Feb 2022 | |
| Seed | $5.5M | Oct 2021 | |
| Series E | $105M | Aug 2021 | |
| BBunjang | Unknown | — | Jan 2020 |
| Series A | $180M | Feb 2019 | |
| Series A | $4.8M | Jul 2012 | |
| AArvelle Therapeutics | Unknown | — | — |
Page 1 of 2
Top Co-Investors
Ignite Innovation Fund4 shared
Mirae Asset3 shared
UMC Capital2 shared
Andera Partners2 shared
NovaQuest Capital Management2 shared
Animoca Brands2 shared
The Spartan Group2 shared
Dragonfly2 shared
Superscrypt2 shared
Republic Crypto2 shared
Upfront Ventures2 shared
Lux Capital2 shared
Detroit Venture Partners2 shared
Samsung Catalyst Fund1 shared
Hanwha Next Generation Opportunity Fund1 shared
Raptor Group1 shared
EQT Life Sciences1 shared
H.I.G. BioHealth Partners1 shared
GIC Private Limited1 shared
Last updated: 8 September 2026